BDBM352283 (E)-3-(5-Chloro-2-tetrazol-1-yl-phenyl)-N—((S)-9-oxo-19-oxa-8,17,18-triaza-tricyclo[14.2.1.02,7]nonadeca-1(18),2,4,6,12,16-hexaen-15-yl)-acrylamide, and (Z)-3-(5-Chloro-2-tetrazol-1-yl-phenyl)-N—((S)-9-oxo-19-oxa-8,17,18-triaza-tricyclo[14.2.1.02,7]nonadeca-1(18),2,4,6,12,16-hexaen-15-yl)-acrylamide::US10487086, Example 122::US11136327, Example 122::US9802939, 122
SMILES Clc1ccc(c(\C=C\C(=O)N[C@H]2CC=CCCC(=O)Nc3ccccc3-c3nnc2o3)c1)-n1cnnn1
InChI Key InChIKey=SPUGCRWFPANOPP-UHFFFAOYSA-N
Data 3 KI
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 3 hits for monomerid = 352283
Affinity DataKi: 25nMAssay Description:Factor XIa determinations were made in 50 mM HEPES buffer at pH 7.4 containing 145 mM NaCl, 5 mM KCl, and 0.1% PEG 8000 (polyethylene glycol; JT Bake...More data for this Ligand-Target Pair
Affinity DataKi: 25nMAssay Description:The effectiveness of compounds of the present invention as inhibitors of the coagulation Factors XIa, VIIa, IXa, Xa, XIIa, plasma kallikrein or throm...More data for this Ligand-Target Pair
Affinity DataKi: 25nMAssay Description:Factor XIa determinations were made in 50 mM HEPES buffer at pH 7.4 containing 145 mM NaCl, 5 mM KCl, and 0.1% PEG 8000 (polyethylene glycol; JT Bake...More data for this Ligand-Target Pair